Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 2 of 2 publications.

Cheol Lee J, Hung JY, Kim YC, Chang GC, Soo Yoo S, Yang SH, Davis KL, Nagar SP, Taylor A, Yong Lee S, Shih JY. Real-world treatment patterns in patients with EGFR mutation-positive NSCLC receiving a first line, first- or second-generation EGFR tyrosine kinase inhibitor in South Korea and Taiwan. Asian Pac J Cancer Bio. 2021 May 20;6(2). doi: 10.31557/APJCB.2021.6.2.123-132

Galinksy J, Richard S, Morris M. Myeloma patients' self-reported experiences of care and treatment. Cancer Nurs Pract. 2016 Sep 14;15(7):22-6. doi: 10.7748/cnp.2016.e1341